A high IL-6 level was found to increase the risk of NAFLD52, and IL-23 was elevated in NASH patients and was suggested to be indirectly linked with hepatic steatosis and pro-inflammatory response in NAFLD53. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.